Topics

Articles

Study explores how the Inflation Reduction Act’s Drug Price Negotiation Program and its maximum fair prices impact incentives for investments in post-approval activity.

A Look at the Effects of the Inflation Reduction Act 

The merger exponentially grows ONO’s oncology pipeline.

ONO Pharmaceutical Solidifies $2.4 Billion Acquisition of Deciphera

The complex will research solutions for manufacturing antibodies, mRNA applications, and more. 

Merck KGaA Financially Commits $322 Million Toward Research Center

The company adds a top-10 CDMO to its portfolio in the process, while also expanding its commitment to the pharma industry. 

Kühne Holding Inks Deal for Aenova 

The deal further grows the Big Pharma company’s US production capabilities, especially when it comes to global parenteral products.

Eli Lilly Purchases Nexus Pharmaceutical Injectables Manufacturing Plant

Deal gives Incyte access to Escient’s pipeline of oral MRGPR antagonists, including EP262 and EP547. 

Incyte Corporation Inks Deal to Acquire Escient Pharmaceuticals for $750 Million 

Company also purchased equipment for 12 good manufacturing practice clean rooms.

BioHarvest Sciences Expands Operations with New 80,000 Square Foot Facility in Yavne, Israel

Capital also expected to assist the advancement of Evergreen's radiopharmaceutical discovery pipeline into clinical trials. 

Evergreen Theragnostics Raises $26M in Capital to Aid Commercialization Efforts for the Ga-68 DOTATOC Diagnostic Kit

Cohort study examines the potential for spending to significantly decrease for individuals who use these generic versions of biologics. 

Does Biosimilar Competition Result in Lower Out-of-Pocket Costs for Patients?

Analysis determines the suggested value of medications for diabetes if they were closer to production costs. 

Business and Finance